Human Hepatitis B Immunoglobulin (China Biologic Products)
乙型肝炎人免疫球蛋白（泰邦生物集团公司）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman Hepatitis B Immunoglobulin (China Biologic Products)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2006/05/10
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaibang Biotech (Shandong) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaibang Biotech (Shandong) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A